Silvia Sánchez Ramón
Silvia Sánchez Ramón
HEAD OF SERVICE
Inmunologíaen/specialities/inmunologiaAnálisis Clínicos y Bioquímica Clínicaen/specialities/analisis-clinicos-bioquimica-clinica
General Information
Dr. Silvia Sánchez Ramón is an eminent specialist in immunology , with a solid academic background that includes a PhD in Medicine from the Universidad Complutense de Madrid. She currently leads the immunology department at Ruber Internacional , where she serves as Head of Department. Her contribution to the field is reflected in her most notable publication, "Evidence of exhausted lymphocytes after the third anti-SARS-CoV-2 vaccine dose in cancer patients," published in Front Oncol in December 2022. She has also been recognized with the Binding Site-SEI Research Award for her work on humoral immunodeficiencies. Dr. Sánchez Ramón is also an active member of the Spanish Society of Immunology , where she serves as President, further solidifying her influence and leadership within the scientific community. Her professional career is a testament to her dedication and commitment to the advancement of clinical immunology .
Key information
- Binding Site-SEI Research Award for publication on humoral immunodeficiencies2022
- Combined Immune Defect in B-Cell Lymphoproliferative Disorders Is Associated with Severe Infection and Cancer Progression
Professional Details
Hospital Ruber Internacional
HEAD OF SERVICE
January 2010
Hospital Universitario Clínico San Carlos
Acting Head of the Immunology Service
January 2012
Mount Sinai Medical Center
Scholarship for Further Studies
January 2007
Hôpital Necker Enfants Malades
Clinical rotation on the management of primary immunodeficiencies
January 2003
Hospital Universitario Clínico San Carlos
Specialist doctor
January 2003
Hospital Gral. Universitario Gregorio Marañón
Specialist doctor
January 2002
Study
Bachelor of Medicine and Surgery
Universidad Complutense de Madrid (UCM)
1991
Doctorate
Universidad Complutense de Madrid (UCM)
2001
Specialized Healthcare Training
Medical Specialist in Immunology
Another qualification
Supervisor of Radioactive Facilities: Field of Application of Nuclear Medicine
Another qualification
Master's Degree in Bioethics and Law: Health and Biotechnology Issues
Profesora invitada Master in Advanced Immunology
Universitat Autónoma de Barcelona
January 2020
Master's Degree in Advanced Therapies
Universidad Francisco de Vitoria
January 2019
Master's Degree in Translational Medicine
Universidad Complutense de Madrid
January 2018
Tutor in university teacher training (FPU) 13/02595
January 2016
Visiting Professor, Biotechnology Degree
Universidad Politécnica de Madrid
January 2014
Associate Professor of Immunology
Universidad Complutense de Madrid
January 2014
Resident Tutor
Hospital Clínico San Carlos
January 2013
Visiting Professor. Medical Collaborator in Practical Teaching
Universidad Complutense de Madrid, Departamento de Microbiología I
January 2005
IGEN0206: Phase II study to evaluate the impact of supplemental IGEN-1806 therapy on the quality of life of patients with metastatic non-small cell lung cancer
2019
INSIGHT002 (FLU002) “International observational study for the characterization of adults with pandemic influenza A (H1N1v)
National Institutes of Health (US NIH) y National Institute of Allergy and Infectious Diseases
2009
ZLB06_005CR (ZLB Behring) Vivaglobin in primary immunodeficiencies
2007
Advancing in precision medicine in the recurrent gestational failure of inflammatory cause
2022
Action BM1305" Action to Focus and Accelerate Cell-based Tolerance-inducing Therapies (A FACTT)
European Cooperation in Scientific and Technical Research
2017
A phase I/II randomized, prospective, double-blind, placebo controlled, single-center study to evaluate the ability of sublingual MV130 to induce the expression of trained immunity in peripheral blood cells
2021
Preclinical Phase of Development of a Vaccine with Dendritic Cells and Regulatory T Lymphocytes for Multiple Sclerosis
2013
BIRTH Project. Biomarkers of Response to Immunoglobulin Replacement Therapy in Patients with Hematological Malignancy
2021
Precision Medicine in Recurrent Reproductive Failure of Inflammatory Origin
2020
AELIX 003: A Phase IIa Randomised, Double-blind, Placebo-controlled Study of HIV 1 Vaccines MVA.HTI and ChAdOx1.HTI With TLR7 Agonist Vesatolimod (GS-9620) in Early Treated HIV-1 Infection
2020
Combined Immune Defect in B-Cell Lymphoproliferative Disorders Is Associated with Severe Infection and Cancer Progression
Article
Evidence of exhausted lymphocytes after the third anti-SARS-CoV-2 vaccine dose in cancer patients
Article
Genomic crossroads between non-Hodgkins lymphoma and common variable immunodeficiency
Article
Immunophenotyping of peripheral blood monocytes could help identify a baseline pro-inflammatory profile in women with recurrent reproductive failure
Article
Secondary Immune Deficiency and Primary Immune Deficiency Crossovers: Hematological Malignancies and Autoimmune Diseases
Article
Binding Site-SEI Research Award for publication on humoral immunodeficiencies
Binding Site-SEI
Second Research Prize , Hospital Clínico San Carlos
Hospital Clínico San Carlos
ABC Health Award 2022 for Best Public Hospital
ABC Salud
Finalist for the Doctoralia Awards in the Allergy and Immunology Area
Doctoralia
Scholarship for Further Studies
Fondo de Investigación Sanitaria
Francisco Tello Muñoz Scholarship
Francisco Tello Muñoz
Make an appointment with this professional
Articles on
View the latest articles in Tu canal de salud.
Vídeos de
Consulta el contenido multimedia de este profesional.
Personal health area: My Quirónsalud
Access any time of the day to take care of your health and that of your family.
My Quirónsalud is your private and secure personal space where you can request and manage your appointments or check your clinical reports without waiting, wherever you are.
Check it out!